Hereditary ATTR amyloid cardiomyopathy

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase I (Other): 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase I (Other)

1 trial
  • Pfizer Inc. Commercial
    TAFAMIDIS
    2023-509241-12-00 1 country 2024 n=12 Orphan
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Pfizer Inc. Commercial 1 Phase I (Other) 0
New trials by year
2024
1
← All indication landscapes